Related Experiment Video
Updated: Oct 20, 2025
07:44
Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
Published on: March 12, 2018
10.3K
A Rapidly Growing Small-Intestinal Metastasis from Lung Cancer
Katsuyoshi Ankoh1, Seiichi Shinji1, Takeshi Yamada1
1Departments of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School.
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi
|September 16, 2021
Summary
Small-intestinal metastasis from lung cancer can rapidly increase in volume, often due to intratumoral hemorrhage. This finding is crucial for understanding oncological emergencies in lung cancer patients.
Area of Science:
- Oncology
- Gastroenterology
Background:
- Small-intestinal metastasis from lung cancer is rare but can lead to severe complications like obstruction and bleeding, presenting an oncological emergency.
- Limited data exists on the progression rate of these metastases, especially in patients undergoing emergency surgery.
Purpose of the Study:
- To analyze the growth rate of small-intestinal metastases from lung cancer.
- To investigate potential causes for rapid tumor volume increase in these metastases.
Main Methods:
- Retrospective analysis of data from 4 patients with small-intestinal metastases from lung cancer.
- Evaluation of tumor diameter changes over a median observation period of 22 days.
- Histopathological analysis to identify causes of rapid tumor growth.
Main Results:
- Small-intestinal metastases showed a rapid average volume increase of 1.48-fold (range, 1.31- to 1.78-fold) within a median of 22 days.
- Histopathology revealed intratumoral hemorrhage as a cause for rapid volume increase in patients with high-grade primary tumor atypia.
Conclusions:
- Small-intestinal metastases from lung cancer exhibit rapid growth, with intratumoral hemorrhage being a significant contributing factor, particularly in cases of high primary tumor atypia.
- Understanding these rapid changes is vital for managing oncological emergencies and guiding treatment strategies.
